Nanoliposomal irinotecan in combination with leucovorin and 5-fluorouracil in advanced biliary tract cancers.

Allo, Gabriel; Can, Ahu Damla; Wahba, Roger; Vogel, Nils; Goeser, Tobias; Kütting, Fabian; Waldschmidt, Dirk

Allo, Gabriel; Can, Ahu Damla; Wahba, Roger; Vogel, Nils; Goeser, Tobias; Kütting, Fabian; Waldschmidt, Dirk.

Afiliação

Allo G; Department for Gastroenterology and Hepatology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany.
Can AD; Department for Gastroenterology and Hepatology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany.
Wahba R; Department of General, Visceral and Cancer and Transplant Surgery, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany.
Vogel N; Department for Gastroenterology and Hepatology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany.
Goeser T; Department for Gastroenterology and Hepatology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany.
Kütting F; Department for Gastroenterology and Hepatology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany.
Waldschmidt D; Department for Gastroenterology and Hepatology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany.

Mol Clin Oncol ; 16(2): 52, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35070301

Palavras-chave

biliary tract cancer; liposomal irinotecan; overall survival; progression free survival; second-line chemotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google